NervGen Pharma Price To Sales Ratio Over Time
| NGEN Stock | CAD 3.09 0.11 3.69% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out NervGen Pharma Performance and NervGen Pharma Correlation. NervGen |
Cross Equities Price To Sales Ratio Analysis
Compare NervGen Pharma Corp and related stocks such as NervGen Pharma Corp, Medicenna Therapeutics, and Arch Biopartners Price To Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ARCH | 445 | 445 | 445 | 164 | 426 | 618 | 618 | 618 | 618 | 1.2 K | 26.9804 | 194 | 34.3246 | 1.8691 | 1.68 | 1.6 |
NervGen Pharma Corp and related stocks such as NervGen Pharma Corp, Medicenna Therapeutics, and Arch Biopartners Price To Sales Ratio description
Price to Sales Ratio is figured by comparing NervGen Pharma Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on NervGen Pharma sales, a figure that is much harder to manipulate than other NervGen Pharma Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
| NervGen Pharma Corp | NGEN |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 112-970 Burrard Street, |
| Exchange | TSX Venture Exchange |
CAD 3.09
Additional Tools for NervGen Stock Analysis
When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.